ABL1 Antikörper (C-Term)
Kurzübersicht für ABL1 Antikörper (C-Term) (ABIN2613831)
Target
Alle ABL1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Spezifität
- Recognizes endogenous levels of ABL1 protein.
-
Aufreinigung
- Immunoaffinity purified
-
Immunogen
-
KLH-conjugated synthetic peptide encompassing a sequence within the C-terminal region of human ABL1.
Type of Immunogen: Synthetic peptide
-
-
-
-
Applikationshinweise
- Approved: ICC (1:100 - 1:500), IF, IHC, IHC-P (1:100 - 1:200), WB (1:500 - 1:1000)
-
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- PBS, pH 7.3, 0.01 % sodium azide, 30 % glycerol.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Aliquot to avoid freeze/thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Aliquot to avoid freeze/thaw cycles.
-
-
- ABL1 (C-Abl Oncogene 1, Non-Receptor tyrosine Kinase (ABL1))
-
Andere Bezeichnung
- ABL1 / C-ABL
-
Hintergrund
-
Name/Gene ID: ABL1
Subfamily: Abl
Family: Protein Kinase
Synonyms: ABL1, Bcr/c-abl oncogene protein, Bcr-Abl, Bcr/abl, C-ABL, ABL, JTK7, p150, Tyrosine-protein kinase ABL1, Proto-oncogene c-Abl, V-abl -
Gen-ID
- 25
-
Pathways
- Apoptose, Regulation of Muscle Cell Differentiation, Platelet-derived growth Factor Receptor Signaling, Lipid Metabolism
Target
-